Our most recent BPC-157 certificate of analysis from Sports Technology Labs, available as a PDF download, confirms this, with a purity of 99.85%
Long-term and serious risks: what does science say
Create Educational, Legally Safe Content Develop content explaining GLP-1s generally: how they work, what to expect, risks, and alternatives
It appears in a lot of research and in a variety of contexts
Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability